| __timestamp | Opthea Limited | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 44820000 |
| Thursday, January 1, 2015 | 2361587 | 82080000 |
| Friday, January 1, 2016 | 4472869 | 97130000 |
| Sunday, January 1, 2017 | 5030957 | 121271000 |
| Monday, January 1, 2018 | 4988941 | 153548000 |
| Tuesday, January 1, 2019 | 5196412 | 202541000 |
| Wednesday, January 1, 2020 | 6652774 | 245164000 |
| Friday, January 1, 2021 | 18418247 | 285773000 |
| Saturday, January 1, 2022 | 24827066 | 325998000 |
| Sunday, January 1, 2023 | 41896408 | 332540000 |
| Monday, January 1, 2024 | 15488619 |
Unleashing insights
In the ever-evolving landscape of biotechnology, operational efficiency is key. Opthea Limited and PTC Therapeutics, Inc. have shown contrasting trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Opthea's SG&A expenses surged by over 1,500% from 2014 to 2023, peaking in 2023. In contrast, PTC Therapeutics, Inc. experienced a steady increase, with expenses growing by approximately 640% over the same period. This divergence highlights differing strategic priorities and operational scales. Opthea's expenses spiked notably in 2021, while PTC Therapeutics maintained a more consistent upward trajectory. The data for 2024 is incomplete, leaving room for speculation on future trends. Understanding these financial dynamics offers valuable insights into each company's operational strategies and market positioning.
Cost Management Insights: SG&A Expenses for AstraZeneca PLC and Opthea Limited
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Opthea Limited
Cost Management Insights: SG&A Expenses for Genmab A/S and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Incyte Corporation vs PTC Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Corcept Therapeutics Incorporated and Opthea Limited
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Opthea Limited and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Opthea Limited or Xencor, Inc.
PTC Therapeutics, Inc. vs Perrigo Company plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or MannKind Corporation